Amcasertib

Overview

Amcasertib (BBI503) is an orally activate cancer stemness kinase inhibitor that enhances apoptosis . Amcasertib inhibits the expression of NANOG and CD133 and cell viability in PC-9/GR cells.

Application

Products | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-17602
• CAS No.: 1129403-56-0
• Molecular Formula: C31H33N5O2S
• Molecular Weight: 539.69
• Purity: 98.03%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1.25 mg/mL (2.32 mM); Clear solution
• Availability: In-stock

Source

Original product source